2[1]Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000,93(1～2): 19-25.
3[2]Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med, 1990,323: 757-758.
4[3]Raine A E G, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med, 1986,315: 533-537.
5[4]Yoshimura M, Yasue H, Okumura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87: 464-469.
6[5]Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994,90: 195-203.
7[6]Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92: 1558-1564.
8[7]Arakawa N, Nakamura M, Aoki H, et al. Relati-onship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology, 1994,85:334-340.
9[1]Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
10[2]Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001, 39(11):1171-1176.
3Kjekshus J,Pedersen TR,OlssonAG,et al.The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease[J].J Card Fail,1997,3(4):249-254.
4Lewis SJ,Moye LA,Sacks FM,et al.Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range[J].Ann Intern Med,1998,129(9):681-689.
5Ankrast P,Yndestad A,Damas JK,et al.Inflammation and chronic heart failure potential the rapeutic role of intravenous immunoglobulin[J].Autoimmun Rev,2004,3(3):221-227.
6Porter KE,Turner NA,O′Reagn DJ,et al.Simvasatin Reduces Human Atrial Myofibroblast Proliferation Indepently of Cholesterol Lowering Via Inhibition of RhoA[J].Cardiovasc Res,2004,61(4):745-755.
7Sola S,Mir MQ,Rajagopalan S,et al.Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure[J].J Card Fail,2005,11(8):607-612.
8Node K.Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy[J].Circulation,2003,108(6):839-843.
9Ross R. Atherosclerosis: an inflammatory disease [ J ]. N Engl J Med,1999(340) :115 - 126.
10Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention [ J ]. Circulation,2003 (3) :363 - 369.
